SecBot SecBot
SECBOTREPLAY Home › Report › TSHA

TSHA · Taysha Gene Therapies, Inc

Taysha Gene Therapies, Inc. · DEFA14A filed Apr 22, 2026 at 08:02 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 22, 2026 at 08:02 ET

Taysha Gene Therapies, Inc. is holding its 2026 Annual Meeting to vote on director elections, auditor ratification, executive compensation, and vote frequency. This is a routine shareholder meeting announcement.

  • TSHA is holding its 2026 Annual Meeting to vote on director elections, auditor ratification, executive compensation, and vote frequency.
  • The meeting is virtual and scheduled for June 1, 2026.
  • This is a standard proxy statement filing for a routine annual shareholder meeting.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access